206 related articles for article (PubMed ID: 8390251)
1. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
2. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
5. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.
Zhang PL; Mackenzie HS; Troy JL; Brenner BM
J Am Soc Nephrol; 1994 Feb; 4(8):1564-70. PubMed ID: 8025230
[TBL] [Abstract][Full Text] [Related]
6. Biological receptors mediate anti-proliferative action of atrial natriuretic peptide in cultured mesangial cells.
Haneda M; Kikkawa R; Koya D; Sakamoto K; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Apr; 192(2):642-8. PubMed ID: 8387284
[TBL] [Abstract][Full Text] [Related]
7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
8. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
[TBL] [Abstract][Full Text] [Related]
10. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
12. Renal hyperfiltration states: relationship to kallikrein and kinins.
Mayfield RK; Jaffa AA; Edmundson AW; Harvey JN
Agents Actions Suppl; 1992; 38 ( Pt 3)():142-8. PubMed ID: 1281377
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats.
Perico N; Benigni A; Gabanelli M; Piccinelli A; Ròg M; De Riva C; Remuzzi G
Diabetes; 1992 Apr; 41(4):533-8. PubMed ID: 1535057
[TBL] [Abstract][Full Text] [Related]
15. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
16. Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats.
Hirata Y; Suzuki Y; Hayakawa H; Suzuki E; Kimura K; Goto A; Kangawa K; Matsuo H; Omata M
Clin Sci (Lond); 1995 Apr; 88(4):413-9. PubMed ID: 7789042
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus.
Okwueze MI; Opgenorth TJ; von Geldern TW; Vari RC
Am J Physiol; 1994 Feb; 266(2 Pt 2):R572-7. PubMed ID: 8141417
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
19. Alterations in atrial natriuretic peptide and its receptor levels in long-term, streptozotocin-induced, diabetes in rats.
Obineche E; Chandranath I; Adeghate E; Benedict S; Fahim M; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():223-34. PubMed ID: 17151304
[TBL] [Abstract][Full Text] [Related]
20. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
